Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
Clinical trial NCT05635838 · COMPLETED
Trial details
- NCT number
- NCT05635838
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2023-10-19
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.